ejuicedemand.com — FDA Warning Letter, 2026-07-10: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Letter issued · posted to fda.gov .
Subject as published: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
TL;DR
Here's the summary: The FDA Center for Tobacco Products issued a warning letter to ejuicedemand.com (July 10, 2026, Reference RW2602432) after finding the retailer sold Nitro's Cold Brew Smoothies – Mango Coconut Surf e-liquid to a person under age 21, violating section 906(d)(5) of the FD&C Act and rendering the product misbranded under section 903(a)(7)(B). The FDA requested written compliance response within 15 working days and warned that failure to address violations may result in civil penalties, seizure, and/or injunction.
Argus analysis
# FDA Warning Letter Analysis: ejuicedemand.com
**Company and Violations**
The FDA Center for Tobacco Products issued a warning letter to ejuicedemand.com on July 10, 2026, for selling nicotine e-liquid products to a minor. During an FDA investigation, an undercover purchaser under age 21 successfully bought Nitro's Cold Brew Smoothies – Mango Coconut Surf e-liquid from the retailer's website. The company, operating from Doral, Florida, was found to have violated federal tobacco regulations governing online sales and age verification requirements.
**Regulatory Citations**
The violations center on three key statutory provisions under the Federal Food, Drug, and Cosmetic Act. Section 906(d)(5) prohibits any retailer from selling tobacco products to persons under 21 years old. Section 903(a)(7)(B) defines such a sale as misbranding. Section 201(rr) establishes that nicotine-containing products qualify as tobacco products subject to FDA jurisdiction under 21 CFR § 1100.1. These citations reflect FDA's authority over non-combustible nicotine products and the agency's enforcement focus on age-restricted sales channels. The warning also references 21 CFR Parts 1140, 1141, and 1143, which govern tobacco product marketing, labeling, and retailer responsibilities.
**Response Timeline and Industry Considerations**
ejuicedemand.com must submit a written response within 15 working days describing corrective actions and compliance plans. The letter warns that failure to address violations may result in civil penalties, product seizure, or injunction. Peer compliance officers in e-liquid retail should note that FDA continues testing online retailers' age verification systems. Companies should review checkout procedures, payment processing safeguards, and third-party platform compliance. The warning also signals renewed focus on premarket tobacco authorization requirements for new products listed in FDA's Searchable Tobacco Products Database.
Severity context
Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
Regulatory background
Tobacco letters cite the Family Smoking Prevention and Tobacco Control Act, primarily Section 910 (premarket review of new tobacco products) for ENDS / e-vapor SKUs.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER ejuicedemand.com MARCS-CMS 733740 — July 10, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Reference #: RW2602432 Product: Tobacco Recipient: ejuicedemand.com 7753 NW 53rd Street Doral , FL 33166 United States sales@ejuicedemand.com Issuing Office: Center for Tobacco Products United States July 10, 2026 WARNING LETTER To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://ejuicedemand.com and determined that e-liquid products listed there are offered for sale or distribution to consumers in the United States. Under section 201(rr) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. § 321(rr)), these products are tobacco products because they are made or derived from tobacco or contain nicotine from any source, and are intended for human consumption. 1 Certain tobacco products, including e-liquid products, are subject to FDA jurisdiction under section 901 of the FD&C Act (21 U.S.C. § 387a) and 21 C.F.R. § 1100.1, and are required to be in compliance with the requirements in the FD&C Act. Under section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)), it is unlawful for any retailer 2 to sell a tobacco product to any person younger than 21 years of age. 3 This includes tobacco products containing nicotine from any source including cigarettes, smokeless tobacco, cigars, e-cigarettes, and nicotine pouches. Tobacco Product Sold by a Retailer to an Individual Under the Age of 21 is Misbranded Under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)), tobacco products are misbranded if sold or distributed by any retailer to a person younger than 21 years of age in violation of section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)). FDA has determined that your Nitro’s Cold Brew Smoothies – Mango Coconut Surf e-liquid product is misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)) because this product was sold to a person younger than 21 years of age. Specifically, during FDA’s investigation of https://ejuicedemand.com, a person younger than 21 years of age purchased Nitro’s Cold Brew Smoothies – Mango Coconut Surf e-liquid product from your website. Conclusion and Requested Actions It is your responsibility to ensure that your tobacco products and all related labeling and/or advertising on this website, on any other websites (including e-commerce, social networking, or search engine websites), in any other media in which you advertise, and in any retail establishments comply with each applicable provision of the FD&C Act and FDA’s implementing regulations. Failure to address any violations of the FD&C Act, 21 U.S.C. § 301 et seq., and FDA’s implementing regulations, including those in 21 C.F.R. Parts 1140, 1141, and 1143, may lead to regulatory action, including, but not limited to, civil money penalties, seizure, and…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What is the standard FDA response window for a warning letter?
- FDA warning letters typically require a written response within 15 working days of receipt, outlining the corrective and preventive actions the company will take.
- Has ejuicedemand.com had FDA enforcement actions before?
- This is the only FDA Warning Letter Argus HQ has on file for ejuicedemand.com as of 2026-07-21. Argus ingests new FDA enforcement records daily.
- What FDA violations was ejuicedemand.com cited for?
- The FDA Warning Letter to ejuicedemand.com (issuing office: Center for Tobacco Products) cites: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Classification: Tobacco / ENDS.
- When did FDA issue the warning letter to ejuicedemand.com?
- FDA issued the letter (MARCS-CMS 733740) on 2026-07-10 and posted it publicly on fda.gov on 2026-07-21.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). ejuicedemand.com — FDA Warning Letter, 2026-07-10: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-ejuicedemand-com-2026-07-10-tobacco
"ejuicedemand.com — FDA Warning Letter, 2026-07-10: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-ejuicedemand-com-2026-07-10-tobacco.
Argus HQ Research. "ejuicedemand.com — FDA Warning Letter, 2026-07-10: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded." Digital Empire Holdings LLC. Accessed July 22, 2026. https://argushq.ai/fda/warning-letter/fda-wl-ejuicedemand-com-2026-07-10-tobacco.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_ejuicedemand_com_2026_07_10_tobacco_2026,
title = {ejuicedemand.com — FDA Warning Letter, 2026-07-10: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-ejuicedemand-com-2026-07-10-tobacco},
note = {Accessed: July 22, 2026}
}